Bristol-Myers Squibb/BMY

$50.51

0.11%
-
1D1W1MYTD1YMAX

About Bristol-Myers Squibb

Bristol-Myers Squibb Company is a biopharmaceutical company, which is engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for a range of therapeutic classes, which include oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically-synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. Biologics are administered to patients through injections or by intravenous infusion. Its products include Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Yervoy, Sprycel, Reblozyl, Opdualag, Abecma, Zeposia, Breyanzi, Camzyos, Sotyktu, Onureg, Inrebic, Augtyro, and others. It also provides radiopharmaceutical therapeutics.

Ticker

BMY

Sector

Healthcare

Trading on

NYSE

Industry

Biotechnology & Drugs

CEO

Giovanni Caforio

Employees

34,100

Headquarters

Princeton, United States

BMY Metrics

BasicAdvanced
$102.16B
Market cap
13.10
P/E ratio
$3.86
EPS
0.37
Beta
$2.28
Dividend rate
4.75%
Dividend yield

What the Analysts think about BMY

Analyst Ratings

Majority rating from 26 analysts.
Hold

Price Targets

Average projection from 20 analysts.
11.46% upside
High $85.00
Low $41.00
$50.51
Current price
$56.30
Average price target

BMY Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
15.35% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$11.48B
4.66%
Net income
$1.76B
-8.61%
Profit margin
15.35%
-12.68%

BMY Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 11.13%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$2.05
$1.75
$2.00
$1.70
-
Expected
$1.97
$1.98
$1.76
$1.53
$1.57
Surprise
3.92%
-11.43%
13.64%
11.13%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Bristol-Myers Squibb stock

Buy or sell Bristol-Myers Squibb stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing